Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
editorial
. 1993 May;39:1008–1013.

Fibrinogen: A new cardiovascular risk factor?

M C Petch
PMCID: PMC2379653  PMID: 8499779

Full text

PDF
1008

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barker D. J., Meade T. W., Fall C. H., Lee A., Osmond C., Phipps K., Stirling Y. Relation of fetal and infant growth to plasma fibrinogen and factor VII concentrations in adult life. BMJ. 1992 Jan 18;304(6820):148–152. doi: 10.1136/bmj.304.6820.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barker D. J., Meade T. W., Fall C. H., Lee A., Osmond C., Phipps K., Stirling Y. Relation of fetal and infant growth to plasma fibrinogen and factor VII concentrations in adult life. BMJ. 1992 Jan 18;304(6820):148–152. doi: 10.1136/bmj.304.6820.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brozović M. Physiological mechanisms in coagulation and fibrinolysis. Br Med Bull. 1977 Sep;33(3):231–238. doi: 10.1093/oxfordjournals.bmb.a071441. [DOI] [PubMed] [Google Scholar]
  4. Brozović M. Physiological mechanisms in coagulation and fibrinolysis. Br Med Bull. 1977 Sep;33(3):231–238. doi: 10.1093/oxfordjournals.bmb.a071441. [DOI] [PubMed] [Google Scholar]
  5. Carlson L. A., Böttiger L. E., Ahfeldt P. E. Risk factors for myocardial infarction in the Stockholm prospective study. A 14-year follow-up focussing on the role of plasma triglycerides and cholesterol. Acta Med Scand. 1979;206(5):351–360. [PubMed] [Google Scholar]
  6. Carlson L. A., Böttiger L. E., Ahfeldt P. E. Risk factors for myocardial infarction in the Stockholm prospective study. A 14-year follow-up focussing on the role of plasma triglycerides and cholesterol. Acta Med Scand. 1979;206(5):351–360. [PubMed] [Google Scholar]
  7. Connelly J. B., Cooper J. A., Meade T. W. Strenuous exercise, plasma fibrinogen, and factor VII activity. Br Heart J. 1992 May;67(5):351–354. doi: 10.1136/hrt.67.5.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Davies M. J. Successful and unsuccessful coronary thrombolysis. Br Heart J. 1989 May;61(5):381–384. doi: 10.1136/hrt.61.5.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Davies M. J. Successful and unsuccessful coronary thrombolysis. Br Heart J. 1989 May;61(5):381–384. doi: 10.1136/hrt.61.5.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. DeWood M. A., Spores J., Notske R., Mouser L. T., Burroughs R., Golden M. S., Lang H. T. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 1980 Oct 16;303(16):897–902. doi: 10.1056/NEJM198010163031601. [DOI] [PubMed] [Google Scholar]
  11. Gurewich V., Lipinski B., Hyde E. The effect of the fibrinogen concentration and the leukocyte count on intravascular fibrin deposition from soluble fibrin monomer complexes. Thromb Haemost. 1976 Dec 31;36(3):605–614. [PubMed] [Google Scholar]
  12. Gurewich V., Lipinski B., Hyde E. The effect of the fibrinogen concentration and the leukocyte count on intravascular fibrin deposition from soluble fibrin monomer complexes. Thromb Haemost. 1976 Dec 31;36(3):605–614. [PubMed] [Google Scholar]
  13. Kannel W. B., Wolf P. A., Castelli W. P., D'Agostino R. B. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA. 1987 Sep 4;258(9):1183–1186. [PubMed] [Google Scholar]
  14. Kannel W. B., Wolf P. A., Castelli W. P., D'Agostino R. B. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA. 1987 Sep 4;258(9):1183–1186. [PubMed] [Google Scholar]
  15. Kirkham N., Murrells T., Melcher D. H., Morrison E. A. Diagonal earlobe creases and fatal cardiovascular disease: a necropsy study. Br Heart J. 1989 Apr;61(4):361–364. doi: 10.1136/hrt.61.4.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kirkham N., Murrells T., Melcher D. H., Morrison E. A. Diagonal earlobe creases and fatal cardiovascular disease: a necropsy study. Br Heart J. 1989 Apr;61(4):361–364. doi: 10.1136/hrt.61.4.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lee A. J., Smith W. C., Lowe G. D., Tunstall-Pedoe H. Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study. J Clin Epidemiol. 1990;43(9):913–919. doi: 10.1016/0895-4356(90)90075-z. [DOI] [PubMed] [Google Scholar]
  18. Lee A. J., Smith W. C., Lowe G. D., Tunstall-Pedoe H. Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study. J Clin Epidemiol. 1990;43(9):913–919. doi: 10.1016/0895-4356(90)90075-z. [DOI] [PubMed] [Google Scholar]
  19. Martin J. F., Bath P. M., Burr M. L. Influence of platelet size on outcome after myocardial infarction. Lancet. 1991 Dec 7;338(8780):1409–1411. doi: 10.1016/0140-6736(91)92719-i. [DOI] [PubMed] [Google Scholar]
  20. Martin J. F., Bath P. M., Burr M. L. Influence of platelet size on outcome after myocardial infarction. Lancet. 1991 Dec 7;338(8780):1409–1411. doi: 10.1016/0140-6736(91)92719-i. [DOI] [PubMed] [Google Scholar]
  21. Meade T. W., Mellows S., Brozovic M., Miller G. J., Chakrabarti R. R., North W. R., Haines A. P., Stirling Y., Imeson J. D., Thompson S. G. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986 Sep 6;2(8506):533–537. doi: 10.1016/s0140-6736(86)90111-x. [DOI] [PubMed] [Google Scholar]
  22. Meade T. W., Mellows S., Brozovic M., Miller G. J., Chakrabarti R. R., North W. R., Haines A. P., Stirling Y., Imeson J. D., Thompson S. G. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986 Sep 6;2(8506):533–537. doi: 10.1016/s0140-6736(86)90111-x. [DOI] [PubMed] [Google Scholar]
  23. Morris J. N., Everitt M. G., Pollard R., Chave S. P., Semmence A. M. Vigorous exercise in leisure-time: protection against coronary heart disease. Lancet. 1980 Dec 6;2(8206):1207–1210. doi: 10.1016/s0140-6736(80)92476-9. [DOI] [PubMed] [Google Scholar]
  24. Morris J. N., Everitt M. G., Pollard R., Chave S. P., Semmence A. M. Vigorous exercise in leisure-time: protection against coronary heart disease. Lancet. 1980 Dec 6;2(8206):1207–1210. doi: 10.1016/s0140-6736(80)92476-9. [DOI] [PubMed] [Google Scholar]
  25. Paffenbarger R. S., Jr, Hyde R. T., Wing A. L., Steinmetz C. H. A natural history of athleticism and cardiovascular health. JAMA. 1984 Jul 27;252(4):491–495. [PubMed] [Google Scholar]
  26. Perkins K. A. Family history of coronary heart disease: is it an independent risk factor? Am J Epidemiol. 1986 Aug;124(2):182–194. doi: 10.1093/oxfordjournals.aje.a114377. [DOI] [PubMed] [Google Scholar]
  27. Perkins K. A. Family history of coronary heart disease: is it an independent risk factor? Am J Epidemiol. 1986 Aug;124(2):182–194. doi: 10.1093/oxfordjournals.aje.a114377. [DOI] [PubMed] [Google Scholar]
  28. ROSENMAN R. H., FRIEDMAN M., STRAUS R., WURM M., KOSITCHEK R., HAHN W., WERTHESSEN N. T. A PREDICTIVE STUDY OF CORONARY HEART DISEASE. JAMA. 1964 Jul 6;189:15–22. doi: 10.1001/jama.1964.03070010021004. [DOI] [PubMed] [Google Scholar]
  29. ROSENMAN R. H., FRIEDMAN M., STRAUS R., WURM M., KOSITCHEK R., HAHN W., WERTHESSEN N. T. A PREDICTIVE STUDY OF CORONARY HEART DISEASE. JAMA. 1964 Jul 6;189:15–22. doi: 10.1001/jama.1964.03070010021004. [DOI] [PubMed] [Google Scholar]
  30. Renaud S., de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 1992 Jun 20;339(8808):1523–1526. doi: 10.1016/0140-6736(92)91277-f. [DOI] [PubMed] [Google Scholar]
  31. Renaud S., de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 1992 Jun 20;339(8808):1523–1526. doi: 10.1016/0140-6736(92)91277-f. [DOI] [PubMed] [Google Scholar]
  32. St Leger A. S., Cochrane A. L., Moore F. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet. 1979 May 12;1(8124):1017–1020. doi: 10.1016/s0140-6736(79)92765-x. [DOI] [PubMed] [Google Scholar]
  33. Stone M. C., Thorp J. M. Plasma fibrinogen--a major coronary risk factor. J R Coll Gen Pract. 1985 Dec;35(281):565–569. [PMC free article] [PubMed] [Google Scholar]
  34. Stone M. C., Thorp J. M. Plasma fibrinogen--a major coronary risk factor. J R Coll Gen Pract. 1985 Dec;35(281):565–569. [PMC free article] [PubMed] [Google Scholar]
  35. Trip M. D., Cats V. M., van Capelle F. J., Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med. 1990 May 31;322(22):1549–1554. doi: 10.1056/NEJM199005313222201. [DOI] [PubMed] [Google Scholar]
  36. Trip M. D., Cats V. M., van Capelle F. J., Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med. 1990 May 31;322(22):1549–1554. doi: 10.1056/NEJM199005313222201. [DOI] [PubMed] [Google Scholar]
  37. Wilhelmsen L., Svärdsudd K., Korsan-Bengtsen K., Larsson B., Welin L., Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984 Aug 23;311(8):501–505. doi: 10.1056/NEJM198408233110804. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES